PATH trades against a final fair-value range of $8.05-$13.97, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $8.05, high $14.0, with mid-point at $11.0.
Trades close to fair value, so the margin of safety is limited either way.
Fair value
$11
Margin of safety
+1.7%
Confidence
84/100
Moat
6.5/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$10.79Price
Low $8.05
Mid $10.98
High $13.97
PATH trades against a final fair-value range of $8.05-$13.97, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
High switching costs embedded deep
High switching costs embedded deep within enterprise legacy workflows.
Incumbent scale and broad integrations
Incumbent scale and broad integrations in traditional RPA markets.
Cycle upside
Enterprise AI adoption drives massive structural process orchestration needs across sectors.
PATH (PATH)'s balance sheet section reports total assets, total liabilities, shareholders' equity, and the structure of debt versus cash so leverage and liquidity can be read directly.
Balance-sheet quality is tracked through net-debt position, interest-coverage trends, and changes in working capital. Material deterioration is flagged in the numbers-analysis subsection together with the income-statement read.
We report total debt and net debt (debt minus cash) on each balance-sheet snapshot. The trajectory across five years lets the reader judge whether debt is being reduced, held steady, or stepped up to fund operations.
Shareholders' equity is reported alongside book-value-per-share metrics where applicable. Buyback-driven equity declines are separated from operating-loss-driven declines so the reader can interpret the change correctly.
FAQ
PATH — frequently asked questions
Based on our latest analysis, PATH trades close to fair value. The current price is $10.8 versus a composite fair-value midpoint of $11.0 (range $8.05–$14.0), which implies roughly 1.8% upside to the midpoint.
Our composite fair-value range for PATH is $8.05–$14.0, with a midpoint of $11.0. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for PATH's archetype.
Our current rating for PATH is Hold with a confidence score of 84/100. PATH is rated Hold at $10.79 versus the reconciled fair value midpoint of $10.98, implying +1.76% upside/downside. Confidence is separately disclosed at 84/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for PATH are: AI Generative Disruption; Structural Margin Stagnation; Uncontrolled SBC Escalation. The single biggest risk is AI Generative Disruption: Generative AI agents bypass traditional RPA workflows entirely, collapsing gross margins and pipeline growth.
Our current rating for PATH is Hold, issued with a confidence score of 84/100 and a moat score of 6.5/10. The rating reflects the composite fair-value range ($8.05–$14.0) versus the current price of $10.8.
PATH is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for PATH.
